Division of Gastroenterology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
J Gastroenterol. 2011 Jan;46(1):25-30. doi: 10.1007/s00535-010-0295-4. Epub 2010 Aug 6.
Eosinophilic esophagitis (EoE) has been a rarely recognized condition in Asian populations, and its clinical manifestation is rarely documented. Our aim was to describe clinically, endoscopically, and pathologically the features of patients with esophageal eosinophilia, including EoE.
Twelve patients histologically proven to have esophageal eosinophilia were investigated. The histological diagnostic cutoff value was defined as a peak of ≥15 eosinophils/high-power field (HPF) in esophageal biopsies. Symptoms, endoscopic and pathological findings, and treatment outcome were evaluated.
Nine of the 12 patients were male and the 12 patients had a mean age of 47.7 years. Allergic conditions were concurrent in a total of 3 patients. Mild peripheral eosinophilia was observed in only 2 patients. The predominant symptom was solid-food dysphagia, but some patients complained of heartburn, or chest, epigastric, or back pain. Three asymptomatic subjects were also incidentally diagnosed during endoscopic screening. Linear furrows, concentric rings, and white exudates in the esophagus were frequently observed. In 4 of 5 patients who were administered a proton pump inhibitor (PPI), esophageal eosinophilia was histologically decreased or disappeared with symptom relief and endoscopic improvement. In 2 patients unresponsive to PPI, topical steroid therapy, administered by the swallowing of fluticasone propionate, led to symptomatic and histological remission.
The endoscopic recognition of linear furrows, concentric rings, and white exudates is important in the diagnosis of eosinophilic esophageal inflammation. In a subset of patients this condition improves clinicopathologically with PPI treatment, and typical EoE, as strictly defined by unresponsiveness to PPI, appears to be a rather rare condition.
嗜酸性食管炎(EoE)在亚洲人群中是一种罕见的疾病,其临床表现很少被记录。我们的目的是描述食管嗜酸性粒细胞增多症患者的临床、内镜和病理特征,包括 EoE。
对 12 例经组织学证实为食管嗜酸性粒细胞增多症的患者进行了调查。组织学诊断的截断值定义为食管活检中嗜酸性粒细胞峰值≥15/高倍视野(HPF)。评估了症状、内镜和病理发现以及治疗结果。
12 例患者中 9 例为男性,平均年龄为 47.7 岁。共有 3 例患者存在过敏情况。仅 2 例患者观察到轻度外周嗜酸性粒细胞增多。主要症状是固体食物吞咽困难,但有些患者抱怨烧心、胸骨后、上腹部或背部疼痛。3 名无症状患者也在内镜筛查中偶然诊断。食管中经常观察到线性沟纹、同心环和白色渗出物。在接受质子泵抑制剂(PPI)治疗的 5 例患者中的 4 例中,食管嗜酸性粒细胞增多症的组织学减少或消失,症状缓解和内镜改善。在 2 例对 PPI 无反应的患者中,通过吞咽丙酸氟替卡松进行局部皮质类固醇治疗导致症状和组织学缓解。
线性沟纹、同心环和白色渗出物的内镜识别对嗜酸性食管炎症的诊断很重要。在一部分患者中,这种情况通过 PPI 治疗在临床病理上得到改善,而典型的 EoE,如对 PPI 无反应所严格定义的,似乎是一种相当罕见的情况。